A Novel Series of Coumarin Derivatives That Exert Osteoblastogenic Effects in Mesenchymal Stem Cells and Osteogenic Effects in Ovariectomized Female Rats
Takashima S., Morishita K., Yamamoto M., Ando M., Kawai S., Otake K., Shoji Y., Hinoi E., Kitao T., Shirahase H.
Chem. Pharm. Bull. 72(12):1084-1104. 2024.
CDK8 inhibitor KY-065 rescues skeletal abnormalities in achondroplasia model mice
Sadamori K., Kubo T., Yoshida T., Yamamoto M., Shibata Y., Fukasawa K., Tokumura K., Horie T., Kadota T., Yamakawa R., Hojo H., Tanaka N., Kitao T., Shirahase H., and Hinoi E#.
Biochim Biophys Acta Mol Basis Dis 1871(3):167626. 2024.
Association between Fat-Soluble Vitamin Metabolic Process and Glioma Progression
Sasaki Y., Tokumura K., Yoshimoto M., and Hinoi E#.
Biol. Pharm. Bull. 47(10):1682-1689. 2024.
Synthesis and Evaluation of a Novel Series of Diphenylamine and Diphenylether Derivatives with Osteoblastogenic and Osteogenic Effects via CDK8 Inhibition
Morishita K., Yamamoto M., Takashima S., Ando M., Kawai S., Otake K., Shoji Y., Hinoi E., Kitao T., Shirahase H.
Chem. Pharm. Bull. 72(10):862-883. 2024.
Role of Erk5 expressed in bone marrow mesenchymal stem cells on bone homeostasis and its potential applications in cancer treatment Oncoscience
Horie T., and Hinoi E#.
Oncoscience 11:45-46. 2024.
Role of proteoglycan synthesis genes in osteosarcoma stem cells
Osumi R., Sugihara K., Yoshimoto M., Tokumura K., Tanaka Y., and Hinoi E#.
Front. Oncol. 14:1325794. 2024.
Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats
Yamamoto M., Shibata Y., Ito Y., Fukui M., Kioka H., Shoji Y., Kitao T., Shirahase H., and Hinoi E#.
Biol. Pharm. Bull. 47(3):669-679. 2024.
The Bioinformatics Identification of Potential Protein Glycosylation Genes Associated with a Glioma Stem Cell Signature
Tokumura K., Sadamori K., Yoshimoto M., Tomizawa A., Tanaka Y., Fukasawa K., and Hinoi E#.
BioMedInformatics 4(1):75-88. 2024.
Characteristics of Scoliosis in Mice Induced by Chondrocyte-specific Inactivation of L-type Amino Acid Transporter 1
Handa M., Demura S., Yokogawa N., Hinoi E., Hiraiwa M., Kato S., Shinmura K., Annen R., Kobayashi M., Yamada Y., Nagatani S., Kurokawa Y., Tsuchiya H.
Spine 49(4):285-293. 2024.